Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1995 1
1996 1
1999 2
2001 1
2002 1
2006 1
2007 2
2008 2
2009 1
2010 1
2011 1
2012 1
2013 3
2014 2
2015 2
2016 4
2017 3
2018 3
2019 3
2020 2
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.
van Trotsenburg P, Stoupa A, Léger J, Rohrer T, Peters C, Fugazzola L, Cassio A, Heinrichs C, Beauloye V, Pohlenz J, Rodien P, Coutant R, Szinnai G, Murray P, Bartés B, Luton D, Salerno M, de Sanctis L, Vigone M, Krude H, Persani L, Polak M. van Trotsenburg P, et al. Among authors: beauloye v. Thyroid. 2021 Mar;31(3):387-419. doi: 10.1089/thy.2020.0333. Thyroid. 2021. PMID: 33272083 Free PMC article. Review.
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. Kelly AS, et al. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. N Engl J Med. 2020. PMID: 32233338 Clinical Trial.
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. Deal CL, et al. J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29. J Clin Endocrinol Metab. 2013. PMID: 23543664 Free PMC article. Review.
Prader-Willi syndrome: A model for understanding the ghrelin system.
Tauber M, Coupaye M, Diene G, Molinas C, Valette M, Beauloye V. Tauber M, et al. Among authors: beauloye v. J Neuroendocrinol. 2019 Jul;31(7):e12728. doi: 10.1111/jne.12728. Epub 2019 May 23. J Neuroendocrinol. 2019. PMID: 31046160 Review.
Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height.
Dotremont H, France A, Heinrichs C, Tenoutasse S, Brachet C, Cools M, De Waele K, Massa G, Lebrethon MC, Gies I, Van Besien J, Derycke C, Ziraldo M, De Schepper J, Beauloye V, Verhulst S, Rooman R, den Brinker M. Dotremont H, et al. Among authors: beauloye v. Front Endocrinol (Lausanne). 2023 Mar 17;14:1113750. doi: 10.3389/fendo.2023.1113750. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008942 Free PMC article.
Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.
Descamps OS, Tenoutasse S, Stephenne X, Gies I, Beauloye V, Lebrethon MC, De Beaufort C, De Waele K, Scheen A, Rietzschel E, Mangano A, Panier JP, Ducobu J, Langlois M, Balligand JL, Legat P, Blaton V, Muls E, Van Gaal L, Sokal E, Rooman R, Carpentier Y, De Backer G, Heller FR. Descamps OS, et al. Among authors: beauloye v. Atherosclerosis. 2011 Oct;218(2):272-80. doi: 10.1016/j.atherosclerosis.2011.06.016. Epub 2011 Jun 17. Atherosclerosis. 2011. PMID: 21762914 Free article. Review.
GHRH excess and blockade in X-LAG syndrome.
Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH, Raverot V, Castermans E, Marbaix E, Maiter D, Brunelle C, Trivellin G, Stratakis CA, Bours V, Raftopoulos C, Beauloye V, Barlier A, Beckers A. Daly AF, et al. Among authors: beauloye v. Endocr Relat Cancer. 2016 Mar;23(3):161-70. doi: 10.1530/ERC-15-0478. Epub 2015 Dec 15. Endocr Relat Cancer. 2016. PMID: 26671997 Free PMC article.
Announcement of an updated Belgian consensus on the assessment and management of obesity.
Van Der Schueren B, Gies I, Barea M, Lannoo M, Beauloye V, Devlieger R, Dirinck E, Lembo B, Vissers D, Verrijken A, Thissen JP. Van Der Schueren B, et al. Among authors: beauloye v. Acta Clin Belg. 2020 Oct;75(5):375-377. doi: 10.1080/17843286.2020.1727665. Epub 2020 Feb 19. Acta Clin Belg. 2020. PMID: 32074026 No abstract available.
40 results